Next |
home / stock / pcvx / pcvx message board
Subject | By | Source | When |
---|---|---|---|
PCVX +16% on phase-2 data for VAX-24: | DewDiligence | investorshub | 04/17/2023 3:04:01 PM |
$PCVX gets BTD for VAX-24 in adult marketinvestors yawn: | DewDiligence | investorshub | 01/05/2023 3:17:24 PM |
$PCVX has around $1B(!) in cash: | DewDiligence | investorshub | 11/08/2022 12:05:41 AM |
Thank you DewDiligence! I'm happy for him. Larry | Phosphene | investorshub | 10/26/2022 10:32:52 PM |
It doesn't affect options already granted. It could | DewDiligence | investorshub | 10/26/2022 7:05:51 PM |
Will this impact Grant's $1.79 options or the | Phosphene | investorshub | 10/26/2022 6:01:54 PM |
Correction$PCVX sells 21.6M* shares @$32.00a 3% discount to | DewDiligence | investorshub | 10/26/2022 1:20:36 PM |
$PCVX sells 18.75M* shares @$32.00a 3% discount to | DewDiligence | investorshub | 10/26/2022 12:29:41 PM |
$PCVX VAXCYTE INC | MiamiGent | investorshub | 10/24/2022 3:32:37 PM |
$PCVX +66% on VAX-24 phase-1/2 data in adults, | DewDiligence | investorshub | 10/24/2022 3:28:21 PM |
The apple doesn't fall far from the tree. | Phosphene | investorshub | 08/30/2022 9:01:40 AM |
$GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc. | Wheat123 | investorshub | 05/31/2022 12:40:50 PM |
$PCVX 3/31/22 cash=$352M (including $108M raised in the | DewDiligence | investorshub | 05/09/2022 9:19:31 PM |
$PCVX expects to report data from phase-1/2 trial of (pneumococcal vaccine) VAX-2 | DewDiligence | investorshub | 04/04/2022 4:17:23 PM |
Are there other companies with conjugate vaccines just | DewDiligence | investorshub | 03/05/2022 12:50:07 AM |
Preferred Recommendation Chances" | Wheat123 | investorshub | 03/05/2022 12:26:40 AM |
$PCVX starts phase-1/2 trial of VAX-24: | DewDiligence | investorshub | 02/23/2022 9:33:45 PM |
PCVX sells 5.075M* shares/prefunded warrants @$20.00a 15% discount to Mondays | DewDiligence | investorshub | 01/13/2022 7:45:43 AM |
After listening to the Needham webcast, Im going | DewDiligence | investorshub | 04/14/2021 2:52:23 PM |
PCVX -18% on VAX-24 delay reported last night | DewDiligence | investorshub | 03/30/2021 4:17:04 PM |
News, Short Squeeze, Breakout and More Instantly...
SAN CARLOS, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it has appointed John Furey, a seasoned industry expert, to its Boa...
2024-06-23 20:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-23 06:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...